Bloomberg Swiss drugmaker Novartis AG said it will scout for medicines that are in earlier stages of development as acquisition price tags climb across the industry. “The price of some of these assets has increased to the point that we don’t feel like we can create value for Novartis shareholders,’’ Chief Executive Officer Joe Jimenez said on a conference …

  Bloomberg European investors who shunned London’s commercial property in the run-up to the Brexit referendum are flocking back as the weak pound cuts prices and electoral uncertainty on the continent makes the UK seem a good place for buyers to spread their bets. Investors from Europe plowed 1.7 billion pounds ($2.2 billion) into the capital’s offices, shops and warehouses …

  Voters in France’s presidential election are being asked to choose between supply-side economic reform, as offered by candidates like centrist Emmanuel Macron and center-right François Fillon, and demand-side reform, as promoted by the National Front’s Marine Le Pen and Jean-Luc Melenchon. The reality is that France needs both at the same time — one without the other won’t work. …